CAR T-cell therapy
SZ4601
Phase 2 mab active
Quick answer
CAR T-cell therapy for Acute Lymphoblastic Leukemia With Failed Remission is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Acute Lymphoblastic Leukemia With Failed Remission
- Phase
- Phase 2
- Modality
- mab
- Status
- active